A phase III trial to evaluate bursectomy for patients with SS/SE gastric cancer (JCOG1001, BURSECTOMY PHASE III)

Phase 3

• Conditions: cT3(SS) or cT4a(SE) gastric cancer

• Registration Number: JPRN-UMIN000003688
• Lead Sponsor: Japan Clinical Oncology Group (JCOG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-06-01
• Study Completion: 2020-06-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Not provided

Exclusion Criteria

1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ 2) Infectious disease with systemic therapy indicated 3) Body temperature is higher than 38 degrees centigrade 4) Women during pregnancy or breast-feeding 5) Severe mental disease 6) Continuous systemic steroid therapy 7) Unstable angina pectoris or history of myocardial infarction within 6 months 8) Uncontrollable hypertension 9) Uncontrollable diabetes millutus or administration of insulin 10) Severe respiratory disease requiring continuous oxygen therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival

Secondary Outcome Measures

Name	Time	Method
Progression-free survival, blood loss, operation time, surgical complications, adverse events of adjuvant chemotherapy